According to Verastem Oncology 's latest financial reports the company's current EPS (TTM) is -ยฃ3.41. In 2022 the company made an earnings per share (EPS) of -ยฃ3.54 an increase over its 2021 EPS that were of -ยฃ3.84.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ3.62 | 2.37% |
2022 | -ยฃ3.54 | -7.93% |
2021 | -ยฃ3.84 | -22.64% |
2020 | -ยฃ4.97 | -73.63% |
2019 | -ยฃ18.84 | 77.88% |
2018 | -ยฃ10.59 | -35.43% |
2017 | -ยฃ16.40 | 78.57% |
2016 | -ยฃ9.18 | -39.51% |
2015 | -ยฃ15.18 | -21.74% |
2014 | -ยฃ19.40 | 13.74% |
2013 | -ยฃ17.05 | 7.06% |
2012 | -ยฃ15.93 | -73.3% |
2011 | -ยฃ59.67 |